help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on October 27, 2005, doi:10.1164/rccm.200508-1302OC

Am. J. Respir. Crit. Care Med., Volume 173, Number 3, February 2006, 281-287

A more recent version of this article appeared on February 1, 2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
200508-1302OCv1
173/3/281    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Perkins, G. D
Right arrow Articles by Gao, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Perkins, G. D
Right arrow Articles by Gao, F.

Submitted on August 22, 2005
Accepted on October 27, 2005

The Beta Agonist Lung Injury Trial (BALTI) a randomised placebo controlled clinical trial

Gavin D Perkins1*, Daniel F McAuley2, David R Thickett3, and Fang Gao4

1 Department of Intensive Care Medicine, Birmingham Heartlands Hospital, Birmingham, United Kingdom; Division of Medical Sciences, University of Birmingham, Birmingham, United Kingdom, 2 Department of Intensive Care Medicine, Birmingham Heartlands Hospital, Birmingham, United Kingdom; Department of Intensive Care Medicine, Queen's University of Belfast, Belfast, United Kingdom, 3 Division of Medical Sciences, University of Birmingham, Birmingham, United Kingdom, 4 Department of Intensive Care Medicine, Birmingham Heartlands Hospital, Birmingham, United Kingdom

* To whom correspondence should be addressed. E-mail: gavin.perkins{at}virgin.net.

Rationale: Experimental data suggest that manipulation of alveolar fluid clearance with {beta} agonists can accelerate the resolution of alveolar oedema and improve survival. Objective: To determine if a sustained infusion of the intravenous salbutamol (albuterol) would accelerate the resolution of alveolar oedema in adult patients with acute lung injury (ALI) or acute respiratory distress syndrome (ARDS). Methods: This was a single centre double blind, randomised controlled trial. Patients with ALI/ARDS were randomised to treatment with intravenous salbutmaol (15 µg kg-1 hr-1) or placebo for 7 days. The primary end-point was extra vascular lung water measured by thermodilution (PiCCOTM) at day 7. Measurements and main results: Sixty-six patients were screened of which 40 met the inclusion criteria and were enrolled during 2001-03. Patients in the salbutamol group had significantly lower lung water at day 7 than the placebo group 9.2(6) vs 13.2(3)ml kg-1, 95% confidence interval difference 0.2-8.3ml kg-1, P=0.038. Plateau airway pressure was lower at day 7 in the salbutamol group 23.9 (3.8)cm H20 vs placebo 29.5(7.2)cm H20, P=0.049. There was a trends towards lower Murray lung injury at day 7 in the salbutamol group 1.7(0.9) vs placebo 2.0 (0.6), P=0.2. Patients in the salbutamol group had a higher incidence of supraventricular arrhythmias (26% vs 10%, P=0.2). Conclusion: Although further research is required to confirm the efficacy and safety of intravenous salbutamol in ALI/ARDS, this trial provides the first proof of principle that in humans with ALI/ARDS, sustained treatment with an intravenous {beta} agonists, reduces extravascular lung water.


Key words: Respiratory Distress Syndrome, Adult; Albuterol; Extravascular Lung Water; Pulmonary edema;




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
M. Bhargava, M. R. Runyon, D. Smirnov, J. Lei, T. J. Groppoli, C. N. Mariash, O. D. Wangensteen, and D. H. Ingbar
Triiodo-L-thyronine Rapidly Stimulates Alveolar Fluid Clearance in Normal and Hyperoxia-injured Lungs
Am. J. Respir. Crit. Care Med., September 1, 2008; 178(5): 506 - 512.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. M. Effros, P. Pornsuriyasak, J. Porszasz, and R. Casaburi
Indicator dilution measurements of extravascular lung water: basic assumptions and observations
Am J Physiol Lung Cell Mol Physiol, June 1, 2008; 294(6): L1023 - L1031.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. A. Matthay
Measurement of extravascular lung water in patients with pulmonary edema
Am J Physiol Lung Cell Mol Physiol, June 1, 2008; 294(6): L1021 - L1022.
[Full Text] [PDF]


Home page
NEJMHome page
M. Eisenhut and J. P. Mizgerd
Acute Lower Respiratory Tract Infection
N. Engl. J. Med., May 29, 2008; 358(22): 2413 - 2414.
[Full Text] [PDF]


Home page
Eur Respir JHome page
G. Zhou, L. A. Dada, and J. I. Sznajder
Regulation of alveolar epithelial function by hypoxia
Eur. Respir. J., May 1, 2008; 31(5): 1107 - 1113.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
M. A. Matthay
Treatment of Acute Lung Injury: Clinical and Experimental Studies
Proceedings of the ATS, April 15, 2008; 5(3): 297 - 299.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
M. A. Matthay and C. S. Calfee
Aerosolized {beta}-Adrenergic Agonist Therapy Reduces Pulmonary Edema Following Lung Surgery
Chest, April 1, 2008; 133(4): 833 - 835.
[Full Text] [PDF]


Home page
ChestHome page
M. Licker, J.-M. Tschopp, J. Robert, J.-G. Frey, J. Diaper, and C. Ellenberger
Aerosolized Salbutamol Accelerates the Resolution of Pulmonary Edema After Lung Resection
Chest, April 1, 2008; 133(4): 845 - 852.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
M. A Matthay and J. Lee
{beta}2 Adrenergic agonist therapy may enhance alveolar epithelial repair in patients with acute lung injury
Thorax, March 1, 2008; 63(3): 189 - 190.
[Full Text] [PDF]


Home page
CJASNHome page
K. D. Liu and M. A. Matthay
Advances in Critical Care for the Nephrologist: Acute Lung Injury/ARDS
Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 578 - 586.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
G D Perkins, F Gao, and D R Thickett
In vivo and in vitro effects of salbutamol on alveolar epithelial repair in acute lung injury
Thorax, March 1, 2008; 63(3): 215 - 220.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
H. O'Brodovich, P. Yang, S. Gandhi, and G. Otulakowski
Amiloride-insensitive Na+ and fluid absorption in the mammalian distal lung
Am J Physiol Lung Cell Mol Physiol, March 1, 2008; 294(3): L401 - L408.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
G. M. Mutlu and P. Factor
Alveolar Epithelial 2-Adrenergic Receptors
Am. J. Respir. Cell Mol. Biol., February 1, 2008; 38(2): 127 - 134.
[Abstract] [Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
H. R. Bream-Rouwenhorst, E. A. Beltz, M. B. Ross, and K. G. Moores
Recent developments in the management of acute respiratory distress syndrome in adults
Am. J. Health Syst. Pharm., January 1, 2008; 65(1): 29 - 36.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. V. Venkateswaran, V. B. Patchell, I. C. Wilson, J. G. Mascaro, R. D. Thompson, D. W. Quinn, R. A. Stockley, J. H. Coote, and R. S. Bonser
Early Donor Management Increases the Retrieval Rate of Lungs for Transplantation
Ann. Thorac. Surg., January 1, 2008; 85(1): 278 - 286.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
I. C. Davis, A. Xu, Z. Gao, J. M. Hickman-Davis, P. Factor, W. M. Sullender, and S. Matalon
Respiratory syncytial virus induces insensitivity to beta-adrenergic agonists in mouse lung epithelium in vivo
Am J Physiol Lung Cell Mol Physiol, August 1, 2007; 293(2): L281 - L289.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
E. B. Milbrandt, A. Ishizaka, and D. C. Angus
Update in Critical Care 2006
Am. J. Respir. Crit. Care Med., April 1, 2007; 175(7): 638 - 648.
[Full Text] [PDF]


Home page
ChestHome page
C. S. Calfee and M. A. Matthay
Nonventilatory Treatments for Acute Lung Injury and ARDS
Chest, March 1, 2007; 131(3): 913 - 920.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. W. Lee and M. A. Matthay
Protein permeability in lung injury: now in real time again?
J Appl Physiol, February 1, 2007; 102(2): 508 - 509.
[Full Text] [PDF]


Home page
ThoraxHome page
G D Perkins, N Nathani, D F McAuley, F Gao, and D R Thickett
In vitro and in vivo effects of salbutamol on neutrophil function in acute lung injury
Thorax, January 1, 2007; 62(1): 36 - 42.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. Eisenhut
Effects of HSP70.1/3 gene knockout on NF-{kappa}B-mediated and cytokine-induced reduction in alveolar ion and fluid transport
Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L365 - L365.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Maggiorini
High altitude-induced pulmonary oedema
Cardiovasc Res, October 1, 2006; 72(1): 41 - 50.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
D. M. Guidot, H. G. Folkesson, L. Jain, J. I. Sznajder, J.-F. Pittet, and M. A. Matthay
Integrating acute lung injury and regulation of alveolar fluid clearance
Am J Physiol Lung Cell Mol Physiol, September 1, 2006; 291(3): L301 - L306.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. B. Maron, H. G. Folkesson, S. M. Stader, and C. M. Hodnichak
Impaired alveolar liquid clearance after 48-h isoproterenol infusion spontaneously recovers by 96 h of continuous infusion
Am J Physiol Lung Cell Mol Physiol, August 1, 2006; 291(2): L252 - L256.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
H. G. Folkesson and M. A. Matthay
Alveolar Epithelial Ion and Fluid Transport: Recent Progress
Am. J. Respir. Cell Mol. Biol., July 1, 2006; 35(1): 10 - 19.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. M. Effros
The beta-Agonist Lung Injury Trial (BALTI).
Am. J. Respir. Crit. Care Med., June 1, 2006; 173(11): 1290 - 1290.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. Zarogiannis, C. Hatzoglou, K. Gourgoulianis, and P.-A. Molyvdas
Pleural Cavity Exploitation in beta-Agonist-treated ARDS Patients.
Am. J. Respir. Crit. Care Med., June 1, 2006; 173(11): 1291 - 1291.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. Frost and M. Wise
The beta-Agonist Lung Injury Trial (BALTI) and the Measurement of Extravascular Lung Water.
Am. J. Respir. Crit. Care Med., June 1, 2006; 173(11): 1290a - 11291.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
G. D. Perkins, D. F. McAuley, D. R. Thickett, and F. Gao
Pleural Cavity Exploitation in beta-Agonist-treated ARDS Patients
Am. J. Respir. Crit. Care Med., June 1, 2006; 173(11): 1291a - 1292.
[Full Text] [PDF]


Home page
Circ. Res.Home page
A. P. Comellas, L. A. Dada, E. Lecuona, L. M. Pesce, N. S. Chandel, N. Quesada, G. R. S. Budinger, G. J. Strous, A. Ciechanover, and J. I. Sznajder
Hypoxia-Mediated Degradation of Na,K-ATPase via Mitochondrial Reactive Oxygen Species and the Ubiquitin-Conjugating System
Circ. Res., May 26, 2006; 98(10): 1314 - 1322.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. A. Matthay and E. Abraham
beta-Adrenergic Agonist Therapy as a Potential Treatment for Acute Lung Injury
Am. J. Respir. Crit. Care Med., February 1, 2006; 173(3): 254 - 255.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2005 American Thoracic Society